|
⚲
|
| Keyboard |
| Steven Elms | |
|---|---|
| Firm | |
| Address | c/o Treeline Biosciences, Inc 500 Arsenal Street Watertown, MA 02472 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Treeline Biosciences Inc | 021-556563 | Director | 200.1 M of 250.0 M |
||
| Marker Therapeutics Inc | 021-533696 | Director | 16.1 M of 16.1 M |
||
| Treeline Biosciences Inc | 021-527039 | Director | 421.8 M of 421.8 M |
||
| Treeline Biosciences Inc | 021-461357 | Director | 261.3 M of 269.3 M |
||
| Treeline Biosciences Inc | 021-397744 | Director | 211.7 M of 220.0 M |
||
| Elevation Oncology Inc | 021-380915 | Executive Officer | 65.0 M of 65.0 M |
||
| 14NER Oncology Inc | 021-344698 | Executive Officer | 5.5 M of 30.0 M |
||
| Earlens Corp | 021-313186 | Director | 9.0 M of 20.0 M |
||
| Earlens Corp | 021-265112 | Director | 72.1 M of 77.3 M |
||
| Lensar Inc | 021-222116 | Director | 16.0 M of 20.0 M |
||
| Advion Inc | 021-219814 | Director | 1.5 M of 1.5 M |
||
| Loxo Oncology Inc | 021-217142 | Director | 23.9 M of 23.9 M |
||
| Earlens Corp | 021-212428 | Director | 39.8 M of 39.8 M |
||
| Lensar Inc | 021-209590 | Director | 10.0 M of 10.0 M |
||
| Lensar Inc | 021-201741 | Director | 17.4 M of 19.8 M |
||
| Loxo Oncology Inc | 021-199892 | Director | 10.0 M | ||
| Pernix Therapeutics Holdings Inc | 021-189722 | Director | 34.0 M of 34.0 M |
||
| ADMA Biologics Inc | 021-189666 | Director | |||
| Lensar Inc | 021-188498 | Director | 5.0 M of 5.0 M |
||
| Ambit Biosciences Corp | 021-186740 | Director | 22.2 M of 44.8 M |
||
| Ambit Biosciences Corp | 021-179014 | Director | 7.1 M of 11.5 M |
||
| Lensar Inc | 021-175097 | Director | 24.0 M of 24.0 M |
||
| ADMA Biologics Inc | 021-174103 | Director | |||
| ADMA Plasma Biologics Inc | 021-174101 | Director | 17.6 M of 17.6 M |
||
| Lensar Inc | 021-170325 | Director | 1.4 M of 1.4 M |
||
| Cenerx Biopharma Inc | 021-169397 | Director | 5.2 M of 5.2 M |
||
| Advion Inc | 021-168887 | Director | 9.2 M of 9.2 M |
||
| Lensar Inc | 021-167107 | Director | 4.0 M of 8.0 M |
||
| Lensar Inc | 021-165303 | Director | 5.0 M of 6.0 M |
||
| Ambit Biosciences Corp | 021-162560 | Director | 22.0 M of 30.0 M |
||
| Lensar Inc | 021-158449 | Director | 2.0 M of 7.0 M |
||
| Ambit Biosciences Corp | 021-149178 | Director | 15.0 M of 15.9 M |
||
| Cenerx Biopharma Inc | 021-146225 | Director | 7.0 M of 7.0 M |
||
| Lensar Inc | 021-145644 | Director | 7.0 M of 12.0 M |
||
| Ambit Biosciences Corp | 021-140630 | Director | 12.0 M of 13.4 M |
||
| Lensar Inc | 021-74758 | Director | 7.1 M of 15.8 M |
||
| Ambit Biosciences Corp | 021-45090 | Director | of 2.4 M |
||
| Cenerx Biopharma Inc | 021-83235 | Director | 3.5 M of 3.5 M |
||
| Aisling Capital Management LP | |||||
| Aisling Capital V LP | 021-343023 | Executive Officer | 144.2 M | 210.0 M | |
| Aisling Capital IV LP | 021-248934 | Executive Officer | 143.1 M of 400.0 M |
506.4 M | |
| Related People Network |
|---|
| Network #209 at Earlens Corp — files alongside 22 co-filers |